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Canine distemper virus (CDV) has recently emerged as an extinc-
tion threat for the endangered Amur tiger (Panthera tigris altaica).
CDV is vaccine-preventable, and control strategies could require
vaccination of domestic dogs and/or wildlife populations. How-
ever, vaccination of endangered wildlife remains controversial,
which has led to a focus on interventions in domestic dogs, often
assumed to be the source of infection. Effective decision making
requires an understanding of the true reservoir dynamics, which
poses substantial challenges in remote areas with diverse host
communities. We carried out serological, demographic, and phylo-
genetic studies of dog and wildlife populations in the Russian Far
East to show that a number of wildlife species are more important
than dogs, both in maintaining CDV and as sources of infection for
tigers. Critically, therefore, because CDV circulates among multiple
wildlife sources, dog vaccination alone would not be effective at
protecting tigers. We show, however, that low-coverage vaccina-
tion of tigers themselves is feasible and would produce substan-
tive reductions in extinction risks. Vaccination of endangered
wildlife provides a valuable component of conservation strategies
for endangered species.
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Tigers (Panthera tigris), among the world’s most iconic carni-vore species, are highly threatened. Having once occupied
vast swathes of Asia from Turkey to the Sea of Japan, fewer than
3,500 tigers now survive with breeding populations in just eight
countries, all of which are fragmented and acutely vulnerable to
extinction (1). The Amur tiger subspecies (P. tigris altaica)
numbers fewer than 550 individuals in two discrete populations
in the Russian Far East and neighboring areas of China.
Results and Discussion
Infectious diseases are increasingly recognized as an extinction
threat for endangered carnivores, and viral pathogens, particu-
larly those linked with domestic dogs (Canis familiaris), have
been the cause of major declines in several populations (2). One
of these pathogens, canine distemper virus (CDV) (Canine
morbillivirus), is commonly associated with domestic dogs but has
also caused disease outbreaks in Serengeti lions (Panthera leo),
Ethiopian wolves (Canis simensis), and Channel Island foxes
(Urocyon littoralis) (3–5), and is now also emerging as a threat to
Amur tigers. CDV was first detected as the cause of death in
Amur tigers in 2003, with subsequent cases confirmed in 2010
(6, 7); population viability analyses showed that CDV increased
the 50-y extinction probability of small populations to over 50%,
an increase of up to 65% (8). These findings have highlighted the
need for active management of disease in the conservation of the
Amur tiger and possibly other more fragmented tiger pop-
ulations across the species’ range.
Several approaches to disease management might be consid-
ered, but effective decision making requires both an understanding
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of which host species act as sources and reservoirs of infection (9)
and a feasibility assessment of potential interventions. For CDV in
the Russian Far East, investigation of reservoirs and implementa-
tion of interventions both pose a substantial challenge. CDV can
infect many host species, with the Amur tiger habitat supporting
highly diverse carnivore communities (17 wild carnivore species
along with domestic dogs) and these areas span large, remote tracts
of land.
Disease interventions could be designed to reduce transmis-
sion to tigers through blocking tactics (e.g., limiting contact be-
tween tigers and potential source populations such as domestic
dogs or other wild carnivores), or by reducing CDV infection
prevalence in reservoir or source populations (e.g., through
vaccination). Alternatively, vaccination could be directed to the
target population of primary concern, in this case tigers. How-
ever, vaccination of endangered wildlife populations has in the
past been beset by controversy (10–12), and this has led con-
servation managers to focus primarily on vaccination of domestic
dogs—established as important sources of infection in other
ecosystems (13, 14). Indeed, conservationists and the general
public often assume domestic dogs must be the source of CDV
infection for endangered wildlife (15, 16).
Our first objective was to generate and evaluate epidemio-
logical evidence to determine the likely relative importance of
domestic dogs and wild carnivore hosts as sources of CDV in-
fection for Amur tigers in the Primorskii Krai region of Russia.
The challenges of sample collection typical of work in such re-
mote regions required us to draw on multiple sources of evidence
to unravel reservoir relationships. These include CDV serologi-
cal data, which provides a reliable indicator of prior infection but
has limited power to discern precise temporal patterns, and virus
sequence data, which has the potential to generate powerful
insights but is hampered by the short duration of CDV infectivity
that limits opportunities for virus detection or isolation.
The first confirmed case of CDV infection was in 2003, and a
retrospective analysis of serological data in Amur tigers supports
the contention that CDV was recently introduced into this
population. CDV antibodies were not detected in any of 18 tigers
sampled prior to 2000 but were detected in 20 of 54 tigers
(37.0%) sampled since then (Table 1).
Serological and demographic data also provide insight on the
role of domestic dogs and other wildlife. CDV antibodies were
detected in unvaccinated dogs from 24 of 37 settlements sampled
and in eight wild carnivore species from eight locations across
Primorskii Krai, confirming that CDV exposure was widespread
(SI Appendix, Fig. S2 and Table S1). Contrary to expectations, we
detected a higher CDV seroprevalence and higher frequency of
CDV outbreaks among dogs in small remote populations than in
more densely populated areas (Table 2 and SI Appendix, Fig. S2).
Of the 32 dogs in the most remote survey community, all had been
born there, and none had traveled to other settlements; never-
theless we detected antibodies in four of the five unvaccinated
dogs sampled, including a 12-mo-old pup. This population is far
too small to maintain the pathogen (17), so the most plausible
explanation for recently infected individuals is that wildlife con-
stitutes an important source of CDV infection for dogs, chal-
lenging a widely held view that the epidemiological cycle is
dominated by dog-to-wildlife transmission.
Patterns of dog movement and population connectivity raise
further questions about the role of domestic dogs as a potential
maintenance population. The estimated size of the dog population
across Primorskii Krai as a whole (467,244 CI: 442,549 to 496,933
dogs) may be large enough to exceed the critical community size
needed to maintain a morbillivirus infection (compared to an es-
timated combined population of the of the four most abundant
wild carnivore species of between 196,850 and 585,900 animals; SI
Appendix, Table S2). However, the relationship between host
population size and CDV persistence is likely to be modified by
the limited connectivity between subpopulations. Survey data in-
dicated that only 6.1% of dogs were permitted complete freedom
of movement, and only 6.9% were ever taken to other settlements,
providing few opportunities for CDV transmission (17).
Analysis of genetic sequence data provides further support for
wildlife acting as a reservoir (SI Appendix, Tables S3 and S4). For
tigers, sequence data were obtained from a combination of live
and postmortem sampling events conducted between 2000 and
2014 [n = 23 tigers, including three known CDV cases from 2003
and 2010 (7)]. We obtained sequence data corresponding to the
hemagglutinin attachment glycoprotein (H-gene, 1,824 bp) from
two previously unidentified cases involving tigers which died in 2006
(GenBank accession no. KX708720) and in 2013 (KX708726). We
also obtained 98.83% of the CDV genome (15,690 bp) from a
formalin-fixed paraffin-embedded brain specimen from the 2003
case (KX774415). From other wildlife, full H-genes were sequenced
from 22 wild carnivores, with viruses detected in each of the 4 y
sampled (2012 to 2015; SI Appendix, Tables S3 and S4), and a
further sequence from a critically endangered Far Eastern leopard
(Panthera pardus orientalis) in 2015 (MK169401). Despite extensive
sampling, only one partial H-gene sequence was obtained from a
domestic dog. This sample was collected during a CDV outbreak in
Vladivostok in 2016 (539 bp, MK169402).
Phylogenetic trees generated using these sequences showed
that tiger, leopard, and other wildlife viruses clustered together
with published sequences from the Arctic-like clade (19), whereas
the dog virus was genetically distinct, aligning within the Asia-4
clade alongside sequences from Thailand and China (20) (Fig. 1).
Additional sequences encoding fusion glycoproteins (F-genes,
1,954 bp) from 13 of these animals added topological support to
the trees generated. The genetic data show that closely related
viruses are infecting a wide range of wild carnivore hosts across a
wide geographic area over a prolonged time period, but there is no
evidence of a relationship to viruses circulating in domestic dogs
across the broader region. Indeed, the results from the single dog
suggest that a distinct epidemiological cycle is occurring there.
Table 1. Summary of virus neutralization results against CDV from large carnivores sampled in
the Russian Far East from 1992 to 1999, and from 2000 to 2014
Animals sampled during 1992 to 1999 Animals sampled during 2000 to 2014
Species +ve N % 95% CI +ve n % 95% CI
Amur tiger 0 18 0.0 0–21.9 20 54 37.0 24.6–51.37
Far Eastern leopard 2 6 33.3 6.0–75.9 0 4 0.0 0.0–60.4
Eurasian lynx 0 0 — — 1 7 14.3 0.8–58.0
Asiatic black bear 0 9 0.0 0.0–37.1 1 17 5.9 0.3–30.8
Brown bear 1 13 7.7 0.4–37.9 1 8 12.5 0.7–53.3
Total 3 46 6.5 1.7–18.9 23 90 25.6 17.2–36.0
For animals sampled on more than one occasion, only the most recent sample in each period is included.
Samples were analyzed by Washington State University using the Onderstepoort strain of CDV.
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However, with more extensive sequence data, it is possible that we
would detect Arctic-like viruses also circulating in dogs, particu-
larly in more remote areas. The key point is that, even without a
full understanding of CDV in dogs, we now have sufficient evi-
dence to suggest that interventions that focus only on domestic
dogs would not be effective at preventing infection of tigers be-
cause of the role of wildlife.
Indeed, together with the serological data, these results are
consistent with an interpretation that wildlife are likely to be key
hosts contributing to CDV maintenance across the Russian Far
Table 2. Results of virus neutralization analyses against CDV for serum samples collected from unvaccinated dogs in the study sites
LLNP, Lazovskii Zapovednik, and SABZ
Study
area
Total no. of
settlements
Dog density,
dogs·km2
No. of settlements
sampled
No. of settlements with recent
outbreaks (n)
No. of positive
dogs (n)
Seroprevalence
(95% CI)
LLNP 64 2.5 27 4 (19) 29 (182) 15.9 (11.1–22.3)
Lazovskii 15 1.1 7 3 (6) 49 (166) 29.5 (22.8–37.2)
SABZ 4 0.3 3 3 (3)* 48 (116) 41.4 (32.4–50.9)
Dog densities were based on extrapolation of human/dog ratios from questionnaire surveys. Neutralizing antibody titers of 1:16 or higher were considered
positive. Seroprevalence is given as the number of positive samples expressed as a percentage of sample size, with lower and upper 95% binomial CIs.
Positives in dogs aged 4 to 12 mo were used to identify recent outbreaks (note that this age class was not represented in all communities). Samples were
tested at the University of Glasgow using the Onderstepoort strain of CDV [cell culture adapted by Bussell and Karzon (18)].
*Denotes that recent outbreaks were detected in one of these communities during surveys in 2012 and 2014.
Fig. 1. A Bayesian phylogeny generated using hemagglutinin gene sequences from canine distemper viruses (CDVs) detected in Primorskii Krai and a se-
lection of published sequences representing recognized CDV clades (in parentheses). Markov Chain Monte Carlo chains were performed using the software
Geneious, version 8.1.8, and the MrBayes plug-in, with the Hasegawa, Kishino, and Yano substitution model. Sequences from Russian wildlife are highlighted
in blue, and the Russian dog virus is highlighted in red; details are provided in SI Appendix, Table S4. Confidence was increased by concatenating comple-
mentary fusion genes where these were available (indicated by *), as a Shimodaira–Hasegawa test indicated a consistent topology for trees based on
hemagglutinin and fusion genes (P = 0.4622). The phocine distemper virus (KC802221) was used as an outgroup (omitted for scale).
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East and an important source of CDV infection for tigers in this
area. There are several potential routes of CDV transmission
from wild carnivores to tigers. The recent detection of CDV in a
raccoon dog killed by a tiger in southern Primorskii suggests that
predation is one such plausible route. Susceptible species (in-
cluding Siberian weasels, sable, raccoon dogs, and wild boar) are
occasionally observed attending tiger kills, providing a possible
opportunity for indirect transmission. Exposure of free-ranging
wild boars in Japan and limited CDV replication in lymphoid
cells of experimentally infected pigs introduce the potential of
transmission from noncarnivore prey (21, 22).
Armed with this evidence, our second objective was to inves-
tigate the feasibility of interventions targeted at wildlife. The lack
of an oral delivery system for a CDV vaccine renders the pros-
pects of controlling infection in a wild reservoir in this ecosystem
logistically untenable. In these circumstances, the only practical
means of reducing the extinction threat would be to consider
individually vaccinating sufficient numbers of tigers to ensure
populations can withstand future outbreaks.
As an essential first step to evaluating the feasibility of this
approach, we confirmed that vaccinated tigers could neutralize
the CDV strain circulating in tiger habitat. Conventional modi-
fied live vaccines have been found to be safe for administration
to captive tigers, and elicit a measurable humoral immune re-
sponse (23). However, the use of these products in field situations
requires assurance of their capacity to induce responses that neu-
tralize the wild CDV strain infecting tigers. Vaccine-induced an-
tibodies must bind to the external H and F glycoproteins of the
wild viral strain to protect otherwise-susceptible tigers. By using a
neutralization assay based on vesicular stomatitis virus (VSV)
pseudotypes (24) bearing the external glycoproteins of the Russian
viral strain (KX708722), we showed that serum from tigers vacci-
nated with a modified live vaccine (Nobivac DP; Merck) could
neutralize the local strain, providing a credible means of protecting
individual tigers from disease (SI Appendix, Fig. S1).
Contemporary CDV vaccines must be delivered by injection,
which places a practical constraint on the rate of vaccine ad-
ministration for a species as rare and cryptic as the Amur tiger.
This would require time-consuming capture operations or, the-
oretically, delivery through a remote darting system (25), with
administration limited to a very small number of tigers each year.
However, low-coverage vaccination approaches have been shown
to be effective during outbreaks of rabies in controlling spread and
preventing the extinction of Ethiopian wolf packs (26). Our pre-
vious individual-based stochastic susceptible–infected–recovered/
dead (SIRD) model with demography demonstrated the high
probability of extinction of Amur tigers over the next 50 y in small
isolated populations in the absence of CDV control strategies (8).
We adapted this population viability analysis to assess the effec-
tiveness of achievable low coverage vaccination strategies to re-
duce the 50-y extinction probability of the population of Amur
tigers in the vicinity of the Land of the Leopard National Park
(LLNP) (Fig. 2), using a demographic susceptible–vaccinated–
infected–recovered/dead (SVIRD) model. Although the LLNP
population is small and genetically isolated, it is of high conser-
vation value as a source for recolonizing formerly occupied habitat
in northeast China (27). The SVIRD model predicted that while
reactive strategies (triggered by the detection of affected tigers)
had little effect on extinction probability, a proactive approach
(vaccinating small numbers of tigers each year without spatial
selection) could substantially reduce the risk of extinction. Using
realistic model parameters based on the findings of the current
study and from the literature, annual vaccination of two tigers
per year reduced the 50-y extinction probability of the LLNP
population from 15.8 to 5.7% at a mean annual cost of less than
$30,000 (Table 3).
A culture of risk aversion has led to a reluctance among
wildlife authorities to consider wildlife vaccination as a means of
preventing the extinction of endangered populations. Specifi-
cally, a now discredited hypothesis that attributed the extinction
of African wild dogs (Lycaon pictus) in the Serengeti to a rabies
vaccination intervention (11) has had far-reaching influence on
conservation policy, with wildlife vaccination often rejected as a
potential conservation tool (10). Instead, wildlife managers have
chosen to rely on vaccination of domestic reservoirs as the pre-
ferred strategy to control pathogen spillover into endangered
species. Our findings counter the assumption that domestic dogs
must be acting as CDV reservoirs for Amur tigers and should
dispel the perception that domestic dogs are the principal source
of infection of CDV. Future policy must be based on a rational
interpretation of epidemiological evidence augmented by ex situ
assessments of vaccine safety and efficacy, and the use of mod-
eling in the design of feasible delivery strategies for a given
context.
Materials and Methods
Dog Demography Surveys. Extreme winter temperatures in Primorskii Krai,
which regularly dip below −15 °C, limit opportunities for dogs to subsist
without human care, and as a result feral dogs are limited or absent, par-
ticularly outside urban centers. For this reason, this study concentrated on
owned dogs, as these constitute the vast majority of dogs within the terri-
tory. Surveys focused on rural settlements within 25-km buffers surrounding
the boundaries of the protected areas LLNP (N42.5°, E130.4° to N43.8°,
E131.7°), Lazovskii Zapovednik (N42.9°, E133.7° to N43.4°, E134.2°), and
Sikhote-Alin Biosphere Zapovednik (SABZ) (N44.8°, E135.7° to N45.7°,
E136.8°). Study areas contained 84 settlements according to the 2010 pop-
ulation census (28). A random selection of 26 rural settlements was gener-
ated for demography surveys (including 16/64 around LLNP, 7/16 around
Lazovskii, and 3/4 around SABZ). Settlements were classified based on the
number of residents present in 2010 as villages (≤1,000 people), towns
(>1,000 people, ≤10,000), large towns (>10,000 people, ≤100,000), or cities
(>100,000 people).
Target household sample sizes were selected using the “pwr” package in R
(29). A minimum sample size of 389 households per study area was chosen
using a two-tailed test to detect differences in proportional responses to
questions of 10%, with an expected response of 50% (which maximizes
required sample size), at a power of 80% and a 95% significance level.
A questionnaire was developed based on published guidelines (30) to
collect information on dog ownership patterns and demography. Ques-
tionnaires were designed and optimized during pilot surveys in July 2012
and November 2012. Interviews were conducted in Russian during visits to
all 26 settlements in November 2012, June 2013, and October 2014. Inter-
viewers visited all residences in villages, explained project objectives to
householders, and requested their compliance in completing the surveys
irrespective of whether they owned dogs. In towns and large towns, it was
impractical to survey all residences. In these settlements, a subset of resi-
dences was randomly generated using published methods (31).
Interviews consisted of a list of questions that were completed in a
semistructuredmanner designed to obtain data at the level of the household,
and on individual dogs currently living in the residence. Household data
included the number of human residents, the number of dogs currently
owned, and the number of dogs owned 10 y previously. Dog-related ques-
tions included vaccination history, frequency of movement beyond the set-
tlement (never, rarely, at least annually, at least monthly, at least weekly),
and freedom to roam unsupervised beyond the property boundaries (never,
rarely/sometimes, part of the day, or all day).
A total of 2,576 rural questionnaires were completed across the 26 study
settlements, with a mean coverage per settlement of 62.8% (SD: 54.2%). The
study areas contained no cities; therefore, a simplified urban questionnaire
was used in the city of Ussuriysk (situated less than 20 km from LLNP) to collect
data describing dog ownership in urban areas. A total of 1,461 urban
questionnaires were completed, focusing on residents interviewed along
major thoroughfares, transport hubs, and outside popular groceries. Inter-
viewees were asked to provide their settlement of residence, and the number
of people and dogs within their household.
Human population growth was estimated for each study settlement using
the census figures from 2002 and 2010. These growth estimates were used to
extrapolate the 2010 census figures in order to obtain estimated population
sizes at the start of the study on November 6, 2012. Ratios of humans to dogs
in surveyed households were used to estimate total numbers of dogs in each
settlement, and also used as the basis for extrapolating numbers of dogs
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across the territory of Primorskii Krai at the start of the study in 2012. For this
purpose, the distribution of human-to-dog ratios for settlements of each size
category was obtained by resampling the data using a subsample of 100
households in each settlement size category, through 1,000 bootstrap rep-
licates. These were fitted to a gamma distribution, which was then used to
estimate the number of dogs in all settlements in each study area, and
throughout Primorskii Krai, across 1,000 replicates.
CDV Exposure History. Samples from tigers and other large-bodied wild
carnivores were obtained from the archives of the Wildlife Conservation
Society (WCS) (Bronx, NY) and were collected from wild carnivores captured
for research purposes or in response to incidents of human–carnivore con-
flict in Primorskii Krai (123 animals), neighboring Khabarovskii Krai (six an-
imals) and Amurskaya Oblast (one animal) between November 1992 and
November 2014. These included samples from 40 tigers described previously
by Goodrich et al. (32).
Serum samples from small-bodied mesocarnivores were obtained from
animals captured specifically for this project, and from archived material.
Captures took place in Lazovskii Zapovednik (during May 2013, and October/
November 2013), and SABZ (April/May 2014), using folding cage traps
(Tomahawk and Havahart). Archived material included samples collected in
LLNP during 2007 to 2008 (by the Federal Scientific Center of East Asian
Terrestrial Biodiversity, Far Eastern Branch of Russian Academy of Sciences,
Vladivostok; and the NIH/National Cancer Institute, Frederick, MD), Lazovskii
Zapovednik during 2008 to 2009 (by the Zoological Society of London), and
from SABZ between 2005 and 2011 (by WCS). Wildlife samples were stored
at −20 °C for up to 8 y prior to export, after which they were transferred
to −80 °C, and shipped using dry ice for analysis.
Serum samples from dogs were collected in conjunction with rural
questionnaire surveys and from 11 additional communities in LLNP, from
dogs whose owners provided informed consent.
Serum from vaccinated tigers was generously donated by E. Ramsay,
College of Veterinary Medicine, University of Tennessee, Knoxville, TN (23).
Antibody titers were measured using virus neutralization at the Wash-
ington Animal Disease Diagnostic Laboratory at Washington State University
(tigers and other large-bodied wild carnivores), and by the Veterinary Di-
agnostic Services at the University of Glasgow (mesocarnivores and domestic
dogs). The methods used in both laboratories were based on Appel and
Robson (33). Final antibody titers were calculated using the Spearman–
Karber method (34). Titers ≥1:16 were considered to be positive to reduce
numbers of false positives due to nonspecific neutralization at lower titers.
Only serum neutralization titers from animals greater than 4 mo old were
included in data analyses, to exclude possible maternally derived antibodies.
Seroprevalence was considered to be the number of animals testing positive,
divided by the total number of animals tested. The R package “prevalence”
(35) was used to calculate 95% binomial confidence intervals for all
seroprevalence estimates.
CDV Molecular Analyses. Domestic dog samples were obtained from two
sources: 1) clinically healthy dogs sampled during household surveys, and 2)
dogs presented for treatment at veterinary clinics. Household samples were
collected from all dogs whose owners consented to sample collection during
Fig. 2. Estimated densities of domestic dogs in the Russian territory of Primorskii Krai represented as a heatmap shaded according to the number of dogs per
1 km2 based on a smoothing radius of 25 km. Tiger distribution based on snow-tracking data are represented by the blue-hatched polygons. Serological data
from live sampled tigers are indicated as pie charts that are scaled based on sample size (with the exception of Sikhote-Alin Biosphere Zapovednik [SABZ]
where sample size is included as text), indicating proportions of positive samples with canine distemper virus (CDV) neutralizing antibodies (black) and
negative samples (white). Confirmed cases of CDV-infected tigers are indicated by black squares. The tiger population around Land of the Leopard National
Park (LLNP) is highlighted in bright green. Study areas LLNP (A), Lazovskii Zapovednik (B), and SABZ (C) are shaded in dull green.
Table 3. Summary of mean 50-y extinction likelihood values for the tiger population in the vicinity of the LLNP, based on 1,000
simulations of a stochastic individual-based population viability model
Vaccination scenario 50-y extinction likelihood, % Mean no. of tigers vaccinated Estimated cost, USD
Control (without CDV) 1.8 0 Not applicable
Control (with CDV) 15.8 0 Not applicable
Reactive strategy 12.8 9.42 287,465
Annual strategy 5.7 100 1,483,724
Costs of implementing a reactive vaccination strategy (vaccinating two tigers when outbreaks are detected) and an annual vaccination strategy
(vaccinating two tigers per year) are estimated in US dollars over the 50-y study period based on the mean number of tigers vaccinated and the costs of
equipping and supplying capture teams (SI Appendix, Table S7).
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household surveys in the study areas of LLNP, Lazovskii Zapovednik, and
SABZ. Nasal swabs were preserved in 300 μL of RNAlater stabilizing reagent
(Qiagen), and whole blood was collected from the cephalic vein into Vacu-
tainers containing EDTA as an anticoagulant (Becton, Dickinson and Com-
pany). All samples were then frozen (at −20 °C or lower) until analysis.
State and private veterinarians in rural and urban areas agreed to par-
ticipate in the collection of clinical samples from sick dogs using a broad case
definition, to maximize the chances of detecting CDV infections. Veteri-
narians were requested to collect conjunctival and nasal swabs in RNAlater
from all dogs displaying any combination of upper respiratory disease,
oculonasal discharge, gastrointestinal disease, and/or neurological signs.
Participating veterinarians were based in the city of Vladivostok, town of
Arsenev, and the districts of Lazovskii, Ussuriyskii, Nadezhdinskii, Khankayskii,
Khasanskii, Dalengorskii, and Partizanskii.
Tissue samples were obtained from small-bodied wild carnivores (meso-
carnivores) with the assistance of state hunting inspectors in the districts of
Terneiskii, Lazovskii, and Pozharskii. These inspectors contacted local fur
trappers authorized to capture fur-bearing species during the winter hunt-
ing seasons of 2011/2012, 2012/2013, and 2013/2014. Additional samples
were obtained from dead mesocarnivores encountered opportunistically,
including road traffic accidents, or animals found dead in the forest, and
from tigers and bears during routine necropsy examinations. Approximately
30 μg of brain tissue from each animal was frozen at −20 °C in 1 mL of
RNAlater. In addition, frozen tissue samples and blood products were
obtained from the archives of WCS. Blood products were also selected for
RNA extraction from animals with measurable titers of serum antibodies of
at least 1:16.
Formalin-fixed paraffin embedded (FFPE) blocks of tissue that had pre-
viously been analyzed by Seimon et al. (7) were selected for further ex-
traction, with the objective of extending published sequences. Following the
animal codes used by Seimon et al. (7), these included the confirmed CDV
cases PT61/Pt 2004, Pt 2010-2, and PT56/Pt 2010-3 (which previously yielded
the CDV sequences: KC579363 [PT61/Pt 2004; partial H gene], KC579361
[PT61/Pt2004; partial P gene], and KC579362 [PT56/Pt2010-3; partial H
gene]), and from suspected case PT90/Pt 2010-1.
Sanger Sequencing. In preparation for RNA extraction, samples were centri-
fuged at 17,562 rcf for 5 min, to facilitate the removal of RNAlater. Tissue
samples were macerated in 200 μL of Buffer RLT Plus (Qiagen), with 1%
β-mercaptoethanol and 5 μL of 3U proteinase-K, vortexed regularly, and in-
cubated for 1 to 3 h at 56 °C, until completely homogenized. RNA was
extracted from tissue homogenates using the AllPrep DNA/RNA Mini Kit
(Qiagen) following manufacturer’s instructions. Extraction of RNA from nasal
swabs, whole blood, blood clots, and scat samples was performed using the
QIAamp Cador Pathogen kit (Qiagen), using manufacturer’s instructions.
All extracts were initially screened by qPCR for a 114-bp fragment of the
P-gene based on previously described protocols (36). Reactions were per-
formed using the Qiagen OneStep RT-PCR kit (Qiagen), and primers CDVF4
and CDVR3, and a TaqMan probe reporting in the FAM channel (SI Ap-
pendix, Table S5). All reactions included a negative control, and a synthetic
CDV sequence as a positive control. Reactions were performed using a Bio-
Rad Minopticon Cycler through 45 cycles, with a transcription step of 20 min
at 50 °C, and an annealing step of 30 s at 60 °C. Wells with characteristic
amplification curves of cycle threshold <38 were considered to be positive.
Samples that tested positive in at least one of three wells then underwent
additional rounds of RT-PCR amplification, using primer sets for a 429-bp
fragment of P-gene (using primers Morb1/Morb2; SI Appendix, Table S5),
and a 291-bp fragment of the H-gene (with primers TSCDVH2-F/TSCDVH3-R;
SI Appendix, Table S5). Reactions were performed using a Bio-Rad Min-
opticon Cycler through 45 cycles, with a transcription step of 30 min at 50 °C,
and an annealing step of 60 s at 45 °C. Products were separated by elec-
trophoresis on a 1.5% agarose gel, and all extracts that produced bands of
the expected molecular weight using both sets of primers were prioritized
for further amplification and sequencing.
Prioritized extracts were amplified by RT-PCR, using four sets of primers
that covered the entire H-gene, modified from Müller et al. (37) (1F/1R,
2Farctic/2Rarctic, 3Farctic/3R, 4Farctic/4R; SI Appendix, Table S5). Reactions
were performed using a Bio-Rad Minopticon Cycler through 45 cycles, with a
transcription step of 30 min at 50 °C, and an annealing step of 55 s at 45 °C.
Products were separated by electrophoresis on a 2.0% agarose gel, and
bands of the expected molecular weight were cleaned using the ExoSAP-IT
reagent (Affymetrix) and directly sequenced in the forward and reverse
directions (Genewiz).
For positive samples that did not yield full-length H-gene consensus se-
quences, DNA cloning techniques were employed to obtain additional
sequences. Further DNA cloning was used to obtain near full-length F-gene
sequences for all samples from which full-length H-genes were sequenced.
RNA extracts were used to prepare cDNA for DNA cloning using the Proto-
Script First Strand cDNA Synthesis Kit (New England Biolabs) following
manufacturer’s protocols, excluding the optional RNA denaturation step.
The first strand DNA product was then amplified using Q5 High-Fidelity DNA
Polymerase (New England Biolabs) and primers RusCDV5primUTR and
RusCDV5primUTR (H-gene) and CDV5primUTR and CDV3primUTR (F-gene)
(SI Appendix, Table S5) in a VERITI 96-well fast thermocycler (Applied Bio-
systems) through 35 cycles (with a denaturation step of 98 °C for 10 s, an
annealing step of 50 to 72 °C for 30 s, and an extension step of 72 °C for 20
s). A second round of DNA amplification was performed using primers
AmurtigercdvHsalF and AmurtigercdvHnot1R (H-gene) and cdvFsal1Fwd and
cdvFnot1R (F-gene) (SI Appendix, Table S5), to tag PCR products with rec-
ognition sites for the SalI and NotI restriction enzymes (New England Biolabs).
DNA fragments were then ligated into the pVR1012 eukaryotic expression
vector (Vical) and transformed into Escherichia coli. Cloned DNA was
amplified, purified, and directly sequenced in the forward and reverse
direction using a Pacific Biosciences PacBio RS II sequencer (operated by
GATC Biotech).
Next-Generation Sequencing.
Sectioning. A 10-y-old FFPE brain tissue sample was available for analysis
(from tiger PT61/Pt 2004). The 20 × 20-μm sections were cut with a micro-
tome in strictly sterile conditions. All areas including the microtome were
treated with 10% bleach and RNA-Zap prior to sectioning of each sample.
Excess paraffin was removed with a fresh scalpel (new scalpels were used for
each biopsy sectioned). Sections were placed in Eppendorf tubes (four per
tube) and 1 mL of xylene was added to each tube in a fume hood. A Qiagen
FFPE RNeasy kit was then used to extract RNA according to the manufac-
turer’s instructions following the xylene extraction protocol. Two protocol
deviations were made. First, the DNase step was reduced from 15 to 5 min in
order to minimize the loss of RNA, and second, RNA was concentrated by
running the whole sample through the same minielute column. RNA was
eluted in 14 μL and frozen at −80 °C prior to use for library preparation.
cDNA synthesis. cDNA synthesis was carried out with random hexamers using
SuperScript III (Invitrogen) according to the manufacturer’s instructions.
Double-stranded cDNA was produced using a NEBNext Second Strand Syn-
thesis kit (New England Biolabs) according to the manufacturer’s instructions.
Library preparation. A KAPA DNA library preparation kit (KAPA BioSciences)
was used to prepare the cDNA for Illumina sequencing, with the following
modifications to standard protocol. In order tominimize sample loss, a “with-
bead” approach was used—AMPureXP beads were retained during all li-
brary preparation steps (38). To compensate for the low sample input, 150
fmol of NEBNext adapter (New England Biolabs) were used for ligation
(a 1,000-fold reduction from standard protocol). Adapter-ligated DNA was
amplified on an ABI 7500 real-time PCR cycler, using a real-time library
amplification kit (KAPA BioSciences). Real-time amplification enables the
reactions to be stopped after the optimum number of PCR cycles, avoiding
over- or under-amplification of library DNA. Index tags were added using
NEBNext multiplex oligos. Library DNA concentration was assessed with the
Qubit 2.0 fluorometer, and an Agilent 2200 TapeStation was used to verify
the final size profile of amplified library DNA and ensure no carryover of
primer dimers. Up to six DNA libraries with appropriate index tags were
pooled, and 2 × 150-nt paired-end sequence datasets were generated on an
Illumina MiSeq using 300-cycle v2 reagents.
Bioinformatic analysis. Raw fastq files were examined for quality using FastQC
and adaptors and low-quality sequence removed. A de novo assembly was
carried out following removal of mammalian DNA sequences using Spades
(39), and Tanoti (https://www.bioinformatics.cvr.ac.uk/Tanoti/) was then
used to map sequence reads to the CDV contig and to the nearest
reference sequence.
Phylogenetic Analysis. Sequences were aligned using the MUSCLE algorithm
within the software Geneious (version 8.1.8) and were edited manually.
Appropriate nucleotide substitution models were identified using jModeltest
2, version 2.1.8 (40, 41), with best-fit models selected based on lowest Akaike
information criterion scores. Phylogenetic trees were constructed for the
H-genes and F-genes using Bayesian inference. The Shimodaira–Hasegawa
test was used to confirm that there was no significant difference between
the topology of the H-gene and F-gene trees (P = 0. 462), and the H-gene
and F-genes were concatenated to increase confidence in the construction
of the final tree. The final tree was based on the GTR+G nucleotide substi-
tution model and was constructed using the Geneious MrBayes plug-in
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(Version 3.2.6), with 1,100,000 iterations, subsampling every 200 trees and
discarding 25% of samples as burn-in (42).
Pseudotype Microneutralization. The recombinant VSV in which the glyco-
protein (G) gene has been deleted (VSVΔG) and replaced with firefly lucif-
erase (luc) has been described (43, 44) and was kindly provided by Michael
Whitt, University of Tennessee Health Science Center, Memphis, TN. An
initial stock of VSVΔGluc bearing VSV-G was used to infect 293T cells
transfected with the VSV-G expression vector pMDG (45). VSVΔGluc (VSV-G)
pseudotypes were recovered, titrated on 293T cells, and used to prepare a
working stock of VSVΔGluc (VSV-G) pseudotypes. To prepare CDV H and F
expression constructs, viral RNA was prepared from mesocarnivore tissue
samples (AllPrep DNA/RNA Mini kit; Qiagen), used to prepare first-strand
cDNA (Transcriptor First-Strand cDNA Synthesis Kit; Roche), and then used
as template in PCRs with the following primers: CDV H Sal, 5′-GTCGAC-AC-
C-ATGCTCCCCTACCAAGACAAGGT-3′; CDV H Not, 5′-GGGCGGCCGC-TTAACG-
GTTACATGAGAATCTTA-3′; CDV F Sal, 5′-GGGTCGAC-ACC-ATGCACAGGGGA-
ATCCCCAAAAG-3′; and CDV F D633 Not, 5-GGGCGGCCGC-TTGCTAGCGTCT-
TTTACAACAGTAAATCAGCA-3′ (Expand High Fidelity PCR system; Roche).
Amplifications were performed with the following thermocycling condi-
tions: denaturation at 94 °C for 5 min, followed by 35 cycles of 94 °C for 30 s,
annealing at 50 °C for 60 s and extension at 72 °C for 120 s, with a final
extension at 72 °C for 10 min. Products were digested with the enzymes SalI
and NotI and cloned into the eukaryotic expression vector VR1012 (Vical).
Canine SLAM-F1 (dogSLAM) was amplified from total RNA prepared from
mitogen-stimulated canine peripheral blood mononuclear cells using PCR
(Q5 High-Fidelity DNA Polymerase; New England Biolabs) and the primers
dogSLAM Bgl, 5′-GCTCAGATCTGAGAGCTTGATGAATTGCCCAG-3′, and dog-
SLAM Sal, 5′-GCTCGTCGACGCTCTCTGGGAACGTCAC-3′. Amplifications were
performed with the following thermocycling conditions: denaturation at
98 °C for 30 s, followed by 30 cycles of 98 °C for 10 s, annealing at 65 °C for
30 s and extension at 72 °C for 60 s, with a final extension at 72 °C for 2 min.
The amplified cDNA was cloned into the pDisplay eukaryotic expression
vector (Life Technologies) using BglII and SalI. The nucleic acid sequences of
all amplified cDNAs were determined externally by Sanger dideoxy chain
termination sequencing (LIGHTrun Sequencing Service; GATC Biotech AG).
All oligonucleotide primers were obtained from Integrated DNA Technologies.
To prepare target cells for the VSV-ΔG(CDV) pseudotypes, HEK293 cells
were transfected with pDisplay-dogSLAM using linear polyethylenimine,
MW 25,000 (Polysciences), and selected in complete medium supplemented
with 800 μg/mL G418. The stably transfected 293-dogSLAM cells were ex-
panded and the surface expression of SLAM confirmed by flow cytometry
using rabbit polyclonal anti-H (Sigma) followed by phycoerythrin (PE)-con-
jugated goat anti-rabbit IgG (Sigma) on a BD Accuri flow cytometer (BD) (24).
Neutralizing antibodies were determined by pseudotype virus neutrali-
zation assay (4). A total of 2 × 104 293-dogSLAM cells was plated into each
well of a 96-well white flat-bottomed plate (Culturplate-96; Perkin-Elmer).
Fourfold serum dilutions were prepared in triplicate in complete medium
ranging from 1:8 to 1:32,768. The diluted serum samples were then added to
the 293-dogSLAM cells followed by 2.5 × 103 TCID50 of VSVΔG(CDV) pseu-
dotype. Plates were incubated for 48 to 72 h at 37 °C, at which time lucif-
erase substrate was added (Steadylite plus; Perkin-Elmer) and the signal
analyzed on a Microbeta 1450 Jet luminometer (Perkin-Elmer). Antibody
titers were calculated by interpolating the point at which there was a 90%
reduction in luciferase activity (90% neutralization).
Vaccination Model. A stochastic population viability model developed by
Gilbert et al. (8) was extended to assess the feasibility of vaccination strat-
egies to reduce the 50-y extinction probability of the small isolated pop-
ulation of Amur tigers in the vicinity of LLNP. The extended model includes a
vaccinated state, giving an SVIRD model with five possible infection states
for each individual tiger—susceptible, vaccinated, infected, recovered and
dead, respectively—on top of their demographic characteristics (described in
ref. 8 and summarized below). The model was discrete time (operating on a
2-wk time step), stochastic, and individual-based and was developed in the
object-oriented programming language Ruby, version 2.3.0.
Following ref. 8, we assumed a closed population of tigers allotted to two
social categories: territory holders that retained ownership of their territory
until death, and nonterritory holders that move throughout the landscape
until encountering a vacant territory. Available habitat was considered
sufficient to support six male territories and nine female territories. Only
territory holders were permitted to reproduce. Parameters used for repro-
duction and survival are summarized in Gilbert et al. (8).
The model was allowed a burn-in period of 40 y to achieve a dynamic
equilibrium in population size, followed by a 50-y study period, whereby
CDV infection is introduced into the population and vaccination commences.
Only simulations where population size at the start of the 50-y study period
fell in the range of 15 to 27 tigers were used to assess 50-y extinction
probability. Populations were assessed over 1,000 simulations and 50-y ex-
tinction probability calculated as the percentage of simulations where
population size declined to zero.
Tigers contracted infections in one of three ways: 1) when predating in-
fected dogs, 2) when predating infected wild carnivores, and 3) during social
contact with infected tigers. The probability of a susceptible tiger acquiring
infection in a given time step is given by 1 − (1 − p)c, where c is the number of
effective contacts per time step (i.e., those where transmission would occur
should the contact be with an infectious individual), and p is the prevalence
of CDV shedding among those contacts, which may be tigers, other wild
carnivores, or domestic dogs. Infection parameters are summarized in SI
Appendix, Table S6. The number of predated dogs and wild carnivores was
generated from a Poisson distribution. To reflect uneven distribution of
dogs, predation was restricted to 80% of territories where human settle-
ments were estimated to occur. All nonterritory holders were considered
capable of dog predation as they were assumed to disperse more widely
including into areas of modified habitat. Predation of wild carnivores was
limited to time steps between early April and early November, when most
species are more active. Tigers maintain territories that largely exclude
members of the same sex; therefore, individuals could only contract CDV
from members of the opposite sex. Dependent cubs automatically contract
CDV if their mothers are infected, and do not survive if their mother dies.
Mortality from CDV infection was estimated as 35% for all ages of tiger, and
surviving tigers recovered after 45 d.
The prevalence of domestic dogs infected with CDV was estimated using a
catalytic model based on the age-stratified serological data collected from
unvaccinated dogs in the study communities (46). The number of seroposi-
tive and seronegative dogs in each age category k is given by npos(k) and
nneg(k), respectively, where the kth age category contains animals in the age
range k − 1 to k years. npos(k) represents the number of dogs surviving in-
fection, and can be used to estimate the number of animals that have been
infected ninf (k) for a given CDV mortality ratio M (defined as the proportion
of infected dogs that die from the infection) given by the following:
ninf(k) = npos(k)(1 −M).
The proportion of dogs infected by a given age is assumed to follow a
catalytic model, i.e., the population is assumed to be subject to a constant
force of infection, λ. We therefore assume that the proportion pinf (k) of dogs
infected by the time they reach age category i is given by the following:
pinf(k) = 1 − e−λak ,
where ak is the midpoint of the kth age category. The likelihood contribu-
tion of each age category i was then given by the following:
ninf(k)log(pinf(k)) + nneg(k)log(1 − pinf(k)).
An estimate of λ was derived using the maximum likelihood with CIs
obtained using the likelihood ratio test.
Assuming that CDV infections did not occur seasonally, mean infection
prevalence Pwas estimated assuming a mean period of infection I of 21 d (47):
P = λ I
365
.
Estimated λ was 0.134 (CI: 0.116 to 0.154) cases per dog per year, which
equates to a mean prevalence of 0.77% assuming M of 0.35 (47).
Control scenarios were run both with and without CDV to determine
baseline extinction probabilities. Two vaccine scenarios were used to simulate
alternative vaccination parameters. These included an annual vaccination
program, in which two tigers were vaccinated each year. A reactive vacci-
nation scenario was also used, where vaccine was only delivered after the
detection of an outbreak and were given to two tigers. The probability of
outbreak detection was given by the following:
1 − (1 − τ)c ,
where c is the expected number of tiger deaths as a consequence of infec-
tion and τ is the probability of finding a dead tiger in a condition where
diagnosis would be possible. The value of τ was estimated to be 0.25, based
on the fate of tigers identified in camera traps in the SABZ between 2006
and 2013 (48).
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Vaccines were administered randomly to adult tigers irrespective of ter-
ritorial status, or stage of infection or immune status. For infected tigers,
vaccination did not act therapeutically; consequently, their infection status
remained unchanged. Vaccines were assumed to be 90% effective (inducing
protective immunity in 90% of individuals that received a single dose) and to
provide lifelong protection from infection with CDV.
Mean costs of vaccination scenarios were estimated over 50 y based on the
mean number of tigers vaccinated across all 1,000 simulations. Budgets
comprised equipment costs to set up each capture team, and the mean costs
of salaries, supplies, living expenses, and fuel per tiger captured (SI Appendix,
Table S7). All equipment was replaced every 10 y to simulate regular wear
and tear. Capture effort per tiger was based on Goodrich et al. (49), which
describes 19 tigers captured over 12,287 trap nights between 1992 and 1998.
Assuming one capture team can monitor a trap line of 15 snares, one tiger
would be captured every 43.1 d. With captures timed for two 43-d trapping
seasons in the spring and autumn, it would be reasonable for one capture
team to capture and vaccinate a mean of two tigers per year. Costs were
estimated over the 50-y study period, and effects of inflation were excluded.
Data Availability. Spreadsheets, model code, and RNA sequence data have
been deposited in Enlighten: Research Data (University of Glasgow data
repository) (50) and the GenBank National Center for Biotechnology Infor-
mation Nucleotide database [accession nos. KX708710–KX708745 (51–85),
KX774415 (86), MK169401 (87), and MK169402 (88)]. All study data are in-
cluded in the article and SI Appendix.
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